Table 2.
Correlation between sensitivity index (Si) and plasminogen activator inhibitor-1 (PAI-1) levels in patients with type 2 diabetes (T2D) and nondiabetics.
T2D | r | P | Nondiabetics | r | P |
| |||||
PAI-1 | PAI-1 | ||||
| |||||
Si | −0.690 | 0.001 | Si | −0.456 | 0.0001 |
Correlation between sensitivity index (Si) and plasminogen activator inhibitor-1 (PAI-1) levels in patients with type 2 diabetes (T2D) and nondiabetics.
T2D | r | P | Nondiabetics | r | P |
| |||||
PAI-1 | PAI-1 | ||||
| |||||
Si | −0.690 | 0.001 | Si | −0.456 | 0.0001 |